Live feed
Filing
SC 13G
SC 13G0001406718-18-000004·Astria Therapeutics, Inc.
Schedule 13G ownership disclosure
CATABASIS PHARMACEUTICALS IN
Security class unavailable · CUSIP: 14875P107
Event date: 2018-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,692,899
- Percent of class
- 7.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001406718-18-000004
- Form type
- SC 13G
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Feb 23, 2018
- Reporting period
- Feb 16, 2018
- Description
- Schedule 13G beneficial ownership